Concepedia

Pierre Grosgurin

PG

6

Publications

636

Citations

6

H-Index

2003

Active since

Affiliations

Debiopharm (Switzerland)(Current)

Tygerberg Hospital

Stellenbosch University

Medical University of Białystok

Pierre Grosgurin is an author at Debiopharm (Switzerland) specializing in pharmacotherapy, medicine, and urology.

Top concepts

Publications per year

2003–2011

6

Publications

6

The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

Robert Flisiak, Andrzej Horban, Philippe Gallay et al. · Hepatology · 2008 · 222 citations

The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients #

Robert Flisiak, S.V. Feinman, Maciej Jabłkowski et al. · Hepatology · 2009 · 221 citations · Full text

Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer

Chris Heyns, Marie-Paule Simonin, Pierre Grosgurin et al. · British Journal of Urology · 2003 · 104 citations

Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer

Eija Lundström, Rupert K. Rencken, Johann H. van Wyk et al. · Clinical Drug Investigation · 2009 · 56 citations

, , +9

95 EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS

David R. Nelson, Reem Ghalib, Mark Sulkowski et al. · Journal of Hepatology · 2009 · 22 citations

, , +9

Rows per page

1–5 of 6